Teratoma epidemiology and demographics

Jump to navigation Jump to search

Teratoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Teratoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Staging

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Teratoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Teratoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Teratoma epidemiology and demographics

CDC on Teratoma epidemiology and demographics

Teratoma epidemiology and demographics in the news

Blogs on Teratoma epidemiology and demographics

Directions to Hospitals Treating Teratoma

Risk calculators and risk factors for Teratoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Epidemiology & Demographics

Teratoma qualifies as a rare disease, but is not extremely rare.In the fetal/neonatal age group, most extracranial germ cell tumors are benign teratomas occurring at midline locations, including sacrococcygeal, retroperitoneal, mediastinal, and cervical regions. Despite the small percentage of malignant teratomas that occur in this age group, perinatal tumors have a high morbidity rate caused by hydrops fetalis and premature delivery.

References

Template:WH Template:WS